Overview
The goal of this clinical trial is to assess the ability of Normothermic Machine Perfusion (NMP) to resuscitate moderately steatotic livers for transplantation in patients. This will be a single-site clinical trial placing donor livers with 30-60% macrosteatosis on NMP, and then transplanting those that meet commonly accepted viability criteria. The results of this study could lead to a trial extending NMP transplantation to severely steatotic livers, further expanding the donor organ pool.
Eligibility
Inclusion Criteria:
- Age 18-80 years
- Listed for liver transplantation at MGH
- Calculated MELD-Na score <= 25
- Able to consent
Exclusion Criteria:
- Status 1a
- Cardiac or pulmonary disease
- Prior liver transplant
- Requiring pressors at the time of liver offer
- MELD<15 and asymptomatic from liver disease